# Levosimendan In Patients Undergoing LVAD Implantation

> **NCT03659851** · — · UNKNOWN · sponsor: **University Hospital Dubrava** · enrollment: 50 (estimated)

## Conditions studied

- Left Ventricular Dysfunction
- Right Ventricular Dysfunction
- Biventricular Failure

## Interventions

- **DRUG:** Levosimendan 2.5 MG/ML Injectable Solution

## Key facts

- **NCT ID:** NCT03659851
- **Lead sponsor:** University Hospital Dubrava
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-06-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2020-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03659851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03659851, "Levosimendan In Patients Undergoing LVAD Implantation". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03659851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*